Retinoid receptor-dependent and -independent effects of N-(4- hydroxyphenyl)retinamide in F9 embryonal carcinoma cells

Cancer Research

Volumn 59, Issue 1, 1999, Pages 14-18

  Clifford, John L ^a   Menter, David G ^a   Wang, Michael ^a   Lotan, Reuben ^a   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL KILLING; CHEMOPROPHYLAXIS; DRUG EFFECT; DRUG RECEPTOR BINDING; EMBRYONAL CARCINOMA; GROWTH INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EMBRYONAL; CELL DEATH; CELL DIFFERENTIATION; FENRETINIDE; MICE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032922598     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
2. Lippman, S. M., Lee, J. J., and Sabichi, A. Cancer chemoprevention: progress and promise. J. Natl. Cancer Inst. (Bethesda), 90: 597-605, 1998.
3. Orfanos, C. E., Zouboulis, C. C., Almond-Roesler, B., and Geilen C. C. Current use and future potential role of retinoids in dermatology. Drugs, 53: 358-388, 1997.
4. Mangelsdorf, D. J., and Evans, R. M. The RXR heterodimers and orphan receptors. Cell, 83: 841-850, 1995.
5. Hogan, B. L. M., Barlow, D., and Tilly, R. F9 teratocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse embryo. Cancer Surv., 2: 115-140, 1983.
6. Atencia, R., Garcia-Sanz, M., Unda, F., and Arechaga, J. Apoptosis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp. Cell Res., 214: 663-667, 1994.
7. Clifford, J. L., Chiba, H., Sobieszczuk, D., Metzger, D., and Chambon, P. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, antiproliferative and apoptotic effects of retinoids. EMBO J., 15: 4142-4155, 1996.
8. Boylan, J., Lohnes, D., Taneja, R., Chambon, P., and Gudas, L. J. Loss of RARγ function by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc. Natl. Acad. Sci. USA, 90: 9601-9605, 1993.
9. Boylan, J., Lufkin, T., Achkar, C. C., Taneja, R., Chambon, P., and Gudas, L. J. Targeted disruption of retinoic acid receptor a (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol., 15: 843-851, 1995.
10. Chiba, H., Clifford, J., Metzger, D., and Chambon, P. Specific and redundant functions of RXR/RAR heterodimers in the control of expression of retinoid target genes in P9 embryonal carcinoma cells. Mol. Cell. Biol., 17: 3013-3020, 1997.
11. Chiba, H., Clifford, J. L., Metzger, D., and Chambon P. Specific and redundant functions of retinoid X receptor-retinoic acid receptor heterodimers in differentiation, proliferation and apoptosis of F9 embryonal carcinoma cells. J. Cell Biol., 139: 735-747, 1997.
12. Dmitrovsky, E. N-(4-Hydroxyphenyl)retinamide activation of a distinct pathway signaling apoptosis. J Natl. Cancer Inst (Bethesda), 89: 1179-1181, 1997.
13. Formelli, F., Barua, A. B., and Olson, J. A. Bioactivites of N-(4-hydroxyphenyl)retinamide and retinoyl β-glucuronide. FASEB J., 10: 1014-1024, 1996.
14. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ., 5: 133-141, 1994.
15. Kazmi, S. M. I., Plante, R. K., Visconti, V., and Lau C. Y. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res., 56: 1056-1062, 1996.
16. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D., Qiu, J., and Pfahl, M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
17. Sabichi, A. L., Hendricks, D. T., Bober, M. A., and Birrer, M. J. Retinoic acid receptor β expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl)retinamide. J. Natl. Cancer Inst. (Bethesda), 90: 597-605, 1998.
18. Delia, D., Aiello, A., Lombardi, L., Pelicci, P. G., Grignani, F., Grignani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U., and Pierotti, M. A. N-(4-Hydroxyphenyl)-retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res., 53: 6036-6041, 1993.
19. Sheikh, M. S., Shao, Z-M., Li, X-S., Ordonez, J. V., Conley. B. A., Wu, S., Dawson, M. I., Han, Q-X., Chao, W., Quick, T., Niles, R. M., and Fontana, J. A. N-(4-Hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis (Lond.), 16: 2477-2486, 1995.
20. Oridate, N., Lotan, D., Xu, X-C., Hong, W. K., and Lotan, R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
21. Haugland, R. P. Probes for live cell function. In: M. T. Z. Spence (ed.), Handbook of Fluorescent Probes and Research Chemicals, pp. 377-398. Eugene, OR: Molecular Probes Inc., 1996.
22. Darzynkiewicz, Z., Li, X., and Gong, J. Assays of cell viability: discrimination of cells dying by apoptosis. In: Z. Darzynkiewicz, J. P. Robinson, and H. A. Crissman (eds.), Methods in Cell Biology, pp. 15-38. New York: Academic Press, 1994.
23. Sani, B. P., Shealy, Y. F., and Hill, D. L. N-(4-Hydroxyphenyl) retinamide: interactions with retinoid-binding proteins/receptors. Carcinogenesis (Lond.), 16: 2531-2534, 1995.
24. Taneja, R., Bouillet, P., Boylan, J. F., Gaub, M-P., Roy, B., Gudas, L. J., and Chambon, P. Reexpression of retinoic acid receptor (RAR)γ or overexpression of RARα or RARβ in RARγ-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Natl. Acad. Sci. USA, 92: 7854-7858, 1995.
25. Dew, S. E., Wardlaw, S. A., and Ong, D. E. Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes. Cancer Res., 53: 2965-2969, 1993.
26. Taimi, M., and Breitman, T. R. N-4-Hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid metabolism. Biochem. Biophys. Res. Commun., 232: 432-436, 1997.
27. Formelli, F., Clerici, M., Campa, T., Di Mauro, M. G., Magni, A., Mascotti, G., Moglia, D., De Palo, G., Costa, A, and Veronesi, U. Five-year administration of fenretinide: pharmacokinetics and effects of plasma retinol concentrations. J. Clin. Oncol., 11: 2036-2042, 1993.
28. Oridate, N., Suzuki, S., Masahiro, H., Mitchell, M., Hong, W. K., and Lotan, R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J. Natl. Cancer Inst. (Bethesda), 89: 1191-1198, 1997.
29. Roberson, K. M., Penland, S. N., Padilla, G. M., Selvan, R. S., Kim, C-S., Fine, R. L., and Robertson, C. N. Fenretinide. Induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cells. Cell Growth Differ., 8: 101-111, 1997.